This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
signaling pathway | 130 |
timo aiii | 119 |
cancer cells | 115 |
mg kg | 110 |
control group | 107 |
cell death | 98 |
western blot | 92 |
results showed | 83 |
nlrp inflammasome | 82 |
induced apoptosis | 80 |
gene expression | 76 |
signaling pathways | 75 |
competing interests | 75 |
smooth muscle | 72 |
cell proliferation | 71 |
previous studies | 67 |
endothelial cells | 66 |
present study | 66 |
blood pressure | 66 |
blot analysis | 63 |
oxidative stress | 63 |
protein expression | 62 |
western blotting | 60 |
inhibitory effect | 58 |
myocardial infarction | 58 |
ics ii | 57 |
room temperature | 57 |
cancer immunotherapy | 57 |
protein levels | 56 |
protein kinase | 55 |
clinical trials | 55 |
dependent manner | 55 |
cell viability | 54 |
lung cancer | 54 |
mouse model | 53 |
cd toxicity | 52 |
significantly increased | 52 |
tumor cells | 51 |
gut microbiota | 51 |
cord uid | 50 |
pharmacol sin | 50 |
doc id | 50 |
sin doi | 50 |
acta pharmacol | 50 |
protective effect | 48 |
growth factor | 47 |
previously described | 47 |
dicer cko | 46 |
expression levels | 45 |
nitric oxide | 45 |
muscle cells | 45 |
heart failure | 42 |
authors declare | 42 |
cleaved caspase | 41 |
mitochondrial biogenesis | 40 |
pancreatic cancer | 40 |
mrna levels | 39 |
cardiovascular disease | 39 |
ng ml | 39 |
protein synthesis | 39 |
sitosterol treatment | 39 |
mitochondrial dynamics | 38 |
protective effects | 38 |
heart disease | 38 |
results suggest | 37 |
important role | 37 |
mitochondrial dysfunction | 36 |
fatty acid | 36 |
db db | 36 |
cell apoptosis | 36 |
cell survival | 36 |
gene therapy | 36 |
type i | 36 |
well plates | 36 |
statistical analysis | 36 |
significantly reduced | 35 |
described previously | 35 |
performed using | 35 |
cell cycle | 35 |
cell membrane | 35 |
three independent | 35 |
skeletal muscle | 35 |
syn aggregation | 34 |
three times | 34 |
vascular endothelial | 34 |
cell lines | 34 |
reperfusion injury | 34 |
cell signaling | 33 |
previous study | 33 |
novel coronavirus | 33 |
nervous system | 33 |
db mice | 33 |
da neurons | 33 |
cell culture | 33 |
body weight | 33 |
endothelial cell | 32 |
total rna | 32 |
gene delivery | 32 |
time pcr | 32 |
transcription factor | 32 |
i ca | 31 |
cerebral ischemia | 31 |
cells treated | 31 |
drg neurons | 31 |
significantly inhibited | 31 |
dna breakage | 31 |
inflammasome activation | 30 |
gas pretreatment | 30 |
angiotensin ii | 30 |
virus infection | 30 |
cancer cell | 30 |
significantly decreased | 30 |
tumor growth | 30 |
wnt pcp | 30 |
influenza virus | 30 |
chinese medicine | 30 |
insulin resistance | 29 |
brain injury | 29 |
inflammatory response | 29 |
primary antibodies | 29 |
results indicated | 29 |
statistically significant | 28 |
pd model | 28 |
way anova | 28 |
ulcerative colitis | 28 |
tumor necrosis | 28 |
science foundation | 28 |
viral rna | 28 |
mg ml | 28 |
tumor microenvironment | 28 |
hypotonic challenge | 28 |
also found | 28 |
culture medium | 27 |
necrosis factor | 27 |
acute respiratory | 27 |
signaling technology | 27 |
cko mice | 27 |
myocardial ischemia | 27 |
traditional chinese | 27 |
animal experiments | 27 |
mm cell | 27 |
syn oligomers | 27 |
breast cancer | 27 |
flow cytometry | 26 |
mitochondrial membrane | 26 |
three decoctions | 26 |
nuclear translocation | 26 |
cancer therapy | 26 |
treated cells | 26 |
host cell | 26 |
iav infection | 26 |
ischemia reperfusion | 26 |
natural science | 26 |
bovine serum | 26 |
keloid fibroblasts | 26 |
cb receptor | 26 |
mechanical hyperalgesia | 25 |
mitochondrial function | 25 |
small molecule | 25 |
ang ii | 25 |
anticancer activity | 25 |
dna damage | 25 |
magl inhibitors | 25 |
independent experiments | 25 |
immune system | 25 |
cardiac function | 25 |
abdominal aortic | 24 |
antihypertensive treatment | 24 |
atp production | 24 |
recent studies | 24 |
amide hydrolase | 24 |
infarct size | 24 |
significant differences | 24 |
potential therapeutic | 24 |
intracellular ca | 24 |
membrane potential | 24 |
hepatocellular carcinoma | 24 |
coronary artery | 23 |
inflammatory responses | 23 |
infected cells | 23 |
mitochondrial respiration | 23 |
cell migration | 23 |
assay kit | 23 |
respiratory syndrome | 23 |
lateral sclerosis | 23 |
acid amide | 23 |
analyzed using | 23 |
lx cells | 23 |
taken together | 23 |
amyotrophic lateral | 23 |
therapeutic target | 23 |
cardiovascular diseases | 23 |
cell line | 23 |
ischemic brain | 23 |
epithelial cells | 23 |
fatty acids | 23 |
per group | 22 |
rat model | 22 |
chloride channel | 22 |
acute myocardial | 22 |
current study | 22 |
asic currents | 22 |
matrix metalloproteinase | 22 |
protein level | 22 |
atherosclerotic disease | 22 |
scale bar | 22 |
membrane fusion | 22 |
mesenchymal transition | 22 |
target gene | 22 |
cb receptors | 22 |
animal models | 22 |
mtor signaling | 21 |
coronary heart | 21 |
syn fibrils | 21 |
apoptosis via | 21 |
endoplasmic reticulum | 21 |
molecular mechanisms | 21 |
receptor agonist | 21 |
viral infection | 21 |
like receptor | 21 |
vascular smooth | 21 |
activated protein | 21 |
control cells | 21 |
type ii | 21 |
stem cells | 20 |
tumor cell | 20 |
dopaminergic neurons | 20 |
pulmonary fibrosis | 20 |
sensory neurons | 20 |
treatment group | 20 |
myocardial injury | 20 |
type diabetes | 20 |
national natural | 20 |
inflammatory bowel | 20 |
tube formation | 20 |
least three | 20 |
cell lung | 20 |
nk cells | 20 |
contains supplementary | 19 |
recent years | 19 |
immune response | 19 |
ampk mtor | 19 |
key role | 19 |
considered statistically | 19 |
authorized users | 19 |
online version | 19 |
mitochondrial fission | 19 |
imaging probes | 19 |
post hoc | 19 |
supplementary material | 19 |
treated mice | 19 |
determine whether | 19 |
mice treated | 19 |
converting enzyme | 19 |
model group | 19 |
induced cardiomyopathy | 19 |
inflammasome pathway | 19 |
severe acute | 19 |
pathological changes | 19 |
extracellular matrix | 18 |
cacc activity | 18 |
synuclein aggregation | 18 |
risk factors | 18 |
secondary antibodies | 18 |
vehicle control | 18 |
itgav promoter | 18 |
three groups | 18 |
per day | 18 |
secondary antibody | 18 |
arginine vasopressin | 18 |
lipid metabolism | 18 |
spike protein | 18 |
infarct volumes | 18 |
protease inhibitor | 18 |
anova followed | 18 |
bar represents | 18 |
syn aggregates | 18 |
nuclear location | 17 |
chloroquine phosphate | 17 |
jnk pathway | 17 |
cells via | 17 |
indicated concentrations | 17 |
coronavirus disease | 17 |
xfzy decoction | 17 |
mediated apoptosis | 17 |
induced inflammation | 17 |
i ph | 17 |
wnt signaling | 17 |
renal fibrosis | 17 |
mesenchymal stem | 17 |
clinical studies | 17 |
dopamine receptors | 17 |
nude mice | 17 |
uuo rats | 17 |
inhibitory effects | 17 |
clinical trial | 17 |
ion channels | 17 |
ex vivo | 17 |
induced cell | 17 |
luciferase activity | 17 |
therapeutic strategy | 17 |
immunofluorescence staining | 17 |
lysis buffer | 17 |
final concentration | 17 |
immune cells | 17 |
thermo fisher | 17 |
intestinal epithelial | 17 |
ischemic injury | 17 |
inflammatory cytokines | 17 |
cardiac dysfunction | 17 |
fetal bovine | 17 |
lung injury | 17 |
central nervous | 17 |
natural killer | 17 |
widely used | 17 |
oxidative injury | 17 |
supplementary table | 17 |
positive control | 16 |
using trizol | 16 |
data showed | 16 |
side effects | 16 |
measured using | 16 |
graphpad prism | 16 |
atypical antipsychotics | 16 |
cycle arrest | 16 |
mapk signaling | 16 |
mitochondrial fusion | 16 |
transcriptional activity | 16 |
smad signaling | 16 |
cell lysates | 16 |
glxbbx decoction | 16 |
negative control | 16 |
er stress | 16 |
adverse effects | 16 |
bowel disease | 16 |
dendritic cells | 16 |
ischemic stroke | 16 |
determined using | 16 |
may contribute | 16 |
like injury | 16 |
proinflammatory cytokines | 16 |
maf axis | 16 |
time points | 16 |
expression profiles | 16 |
tlr myd | 16 |
statistical analyses | 16 |
clinically relevant | 16 |
induced nf | 16 |
external solution | 16 |
dna fragmentation | 15 |
matrix metalloproteinases | 15 |
molecular mechanism | 15 |
activated chloride | 15 |
ldh release | 15 |
general psychopathology | 15 |
luciferase reporter | 15 |
hepatic fibrosis | 15 |
data analysis | 15 |
cmr treatment | 15 |
social functioning | 15 |
oxide synthase | 15 |
intestinal inflammation | 15 |
therapeutic targets | 15 |
dm group | 15 |
wt cells | 15 |
zn protection | 15 |
transgenic mice | 15 |
wt mice | 15 |
signal transduction | 15 |
uuo aa | 15 |
i signaling | 15 |
induced cardiotoxicity | 15 |
adipose tissue | 15 |
gel electrophoresis | 15 |
tyrosine kinase | 15 |
underlying mechanism | 15 |
timosaponin aiii | 15 |
results revealed | 15 |
ca release | 15 |
two groups | 15 |
analysis showed | 15 |
nle treatment | 15 |
trail gene | 15 |
treatment significantly | 15 |
mrna expression | 15 |
results suggested | 14 |
delivery systems | 14 |
jnk signaling | 14 |
underlying mechanisms | 14 |
animal model | 14 |
fisher scientific | 14 |
lewy bodies | 14 |
knockout mice | 14 |
oxygen species | 14 |
ethics committee | 14 |
inflammatory factors | 14 |
iav control | 14 |
syndrome coronavirus | 14 |
trail resistance | 14 |
dependent apoptosis | 14 |
vs vehicle | 14 |
per well | 14 |
review article | 14 |
colon cancer | 14 |
prostate cancer | 14 |
transfected cells | 14 |
cell types | 14 |
target genes | 14 |
data suggest | 14 |
trizol reagent | 14 |
early dn | 14 |
kinase activity | 14 |
endocannabinoid system | 14 |
systematic review | 14 |
reactive oxygen | 14 |
synthesis inhibitor | 14 |
receptor antagonists | 14 |
protective role | 14 |
study showed | 14 |
ng paw | 14 |
closely related | 14 |
cardiovascular risk | 14 |
neurodegenerative diseases | 14 |
zebrafish embryos | 14 |
signalling pathway | 14 |
rna interference | 14 |
mitochondrial morphology | 14 |
induced colitis | 14 |
significant increase | 14 |
hypertension induced | 14 |
binding site | 14 |
therapeutic efficacy | 13 |
small cell | 13 |
drinking water | 13 |
cell adhesion | 13 |
antiangiogenesis effect | 13 |
maf degradation | 13 |
transcription factors | 13 |
cells well | 13 |
aortic aneurysms | 13 |
related protein | 13 |
monoacylglycerol lipase | 13 |
growth inhibition | 13 |
stem cell | 13 |
infectious diseases | 13 |
liver fibrosis | 13 |
similar results | 13 |
significant difference | 13 |
also decreased | 13 |
ib assays | 13 |
engineered cardiac | 13 |
electron microscopy | 13 |
free medium | 13 |
induces apoptosis | 13 |
tumor tissues | 13 |
multiple myeloma | 13 |
immune checkpoint | 13 |
therapeutic effects | 13 |
randomly divided | 13 |
sw cells | 13 |
treated group | 13 |
coronavirus pneumonia | 13 |
cdna microarray | 13 |
quantitative analysis | 13 |
medium containing | 13 |
aa group | 13 |
drug delivery | 13 |
drug treatment | 13 |
dm ab | 13 |
buffered saline | 13 |
positive cells | 13 |
based gene | 13 |
receptor antagonist | 13 |
promising therapeutic | 13 |
amino acids | 13 |
mapk pathway | 13 |
study demonstrated | 13 |
treatment induced | 13 |
santa cruz | 13 |
cardiac fibroblasts | 13 |
related proteins | 13 |
aggregation inhibitors | 13 |
ht receptor | 13 |
induced il | 13 |
faah inhibitors | 13 |
heart tissue | 12 |
different concentrations | 12 |
tamoxifen administration | 12 |
uuo mice | 12 |
ab group | 12 |
chinese patent | 12 |
apoptotic cells | 12 |
binding domain | 12 |
therapeutic potential | 12 |
artery smooth | 12 |
basilar artery | 12 |
faah magl | 12 |
recent study | 12 |
increased expression | 12 |
expression level | 12 |
cd exposure | 12 |
multiple comparisons | 12 |
induced proinflammatory | 12 |
inhibit sars | 12 |
cells transfected | 12 |
binding affinity | 12 |
binding sites | 12 |
cardiac remodeling | 12 |
significantly attenuated | 12 |
plasma membrane | 12 |
also showed | 12 |
myristoyl group | 12 |
dependent nf | 12 |
induced bv | 12 |
catenin signaling | 12 |
aortic aneurysm | 12 |
antiviral effects | 12 |
ect cd | 12 |
recombinant human | 12 |
avian influenza | 12 |
stat activation | 12 |
terminal region | 12 |
reticulum stress | 12 |
cells per | 12 |
channel blockers | 12 |
hepg cells | 12 |
anticancer effect | 12 |
also significantly | 12 |
significantly higher | 12 |
drug development | 12 |
related molecules | 12 |
reverse transcription | 12 |
cannabinoid receptor | 12 |
virus replication | 12 |
antiviral effect | 12 |
diabetes mellitus | 12 |
viral fusion | 12 |
drug targets | 12 |
mass spectrometry | 12 |
significantly suppressed | 11 |
relevant concentrations | 11 |
way analysis | 11 |
oral administration | 11 |
commonly used | 11 |
hr domain | 11 |
proinflammatory mediators | 11 |
signaling cascade | 11 |
inflammatory cells | 11 |
inflammatory effects | 11 |
ischemic heart | 11 |
new therapeutic | 11 |
density lipoprotein | 11 |
important roles | 11 |
lipid rafts | 11 |
tumor immune | 11 |
deficient mice | 11 |
tumor angiogenesis | 11 |
nmt inhibitors | 11 |
cd treatment | 11 |
cobra venom | 11 |
nonviral vectors | 11 |
primary antibody | 11 |
preclinical studies | 11 |
cancer patients | 11 |
glucose tolerance | 11 |
viral replication | 11 |
dawley rats | 11 |
laboratory animals | 11 |
schizophrenic patients | 11 |
amino acid | 11 |
amyloid proteins | 11 |
cell growth | 11 |
hypotonic solution | 11 |
tumor volume | 11 |
diabetic nephropathy | 11 |
hydrogen peroxide | 11 |
results indicate | 11 |
binding pocket | 11 |
solid tumors | 11 |
heart tissues | 11 |
induced injury | 11 |
also observed | 11 |
carcinoma cells | 11 |
parkinson disease | 11 |
cardiac tissues | 11 |
weight loss | 11 |
plasminogen activator | 11 |
plasma acetate | 11 |
preformed fibrils | 11 |
endothelial growth | 11 |
various concentrations | 11 |
antipsychotic drugs | 11 |
artery disease | 11 |
patients treated | 11 |
psychopathology score | 11 |
da neuron | 11 |
antiviral activity | 11 |
significantly lower | 11 |
rat tail | 11 |
may affect | 11 |
ebola virus | 11 |
peroxisome proliferator | 11 |
nuclear condensation | 11 |
critical role | 11 |
renal injury | 11 |
effectively inhibit | 11 |
first time | 11 |
pc cells | 11 |
pooled cell | 11 |
four groups | 11 |
dopamine receptor | 11 |
catalpol treatment | 11 |
bile acid | 11 |
orally administered | 11 |
therapeutic strategies | 11 |
glucose uptake | 10 |
asiatic acid | 10 |
disease progression | 10 |
ca homeostasis | 10 |
uuo group | 10 |
play important | 10 |
may lead | 10 |
small molecules | 10 |
treatment protocol | 10 |
nrf expression | 10 |
results demonstrated | 10 |
ta muscle | 10 |
total protein | 10 |
investigated whether | 10 |
chinese academy | 10 |
basilar arteries | 10 |
viral vectors | 10 |
may also | 10 |
multiple signaling | 10 |
plasma concentration | 10 |
conditional knockout | 10 |
based therapy | 10 |
hoc test | 10 |
enrichment analysis | 10 |
nlrp caspase | 10 |
washed twice | 10 |
separate experiments | 10 |
mediated mitochondrial | 10 |
mt expression | 10 |
essential role | 10 |
sodium dodecyl | 10 |
stroke therapy | 10 |
findings suggest | 10 |
novo protein | 10 |
receptor signaling | 10 |
cells using | 10 |
muscle cell | 10 |
glial cells | 10 |
inflammasome formation | 10 |
remains unclear | 10 |
light microscope | 10 |
ras activation | 10 |
calcium channels | 10 |
innate immune | 10 |
endothelial nitric | 10 |
fluorescent probes | 10 |
transforming growth | 10 |
molecular docking | 10 |
colorectal cancer | 10 |
focal cerebral | 10 |
aiii inhibited | 10 |
human ace | 10 |
noncanonical wnt | 10 |
cold pbs | 10 |
comparisons test | 10 |
hind paw | 10 |
sensing ion | 10 |
cleaved parp | 10 |
conjugated secondary | 10 |
combination treatment | 10 |
significantly ameliorated | 10 |
intrarenal ras | 10 |
dox treatment | 10 |
previously reported | 10 |
immune responses | 10 |
neuroprotective effect | 10 |
pd patients | 10 |
laboratory animal | 10 |
independent pooled | 10 |
transgenic mouse | 10 |
crucial role | 10 |
ripa buffer | 10 |
autophagy activation | 10 |
cell samples | 10 |
cell damage | 10 |
cancer nanomedicine | 10 |
antitumor activity | 10 |
metabolic pathways | 10 |
neurological deficit | 10 |
imbalanced mitochondrial | 10 |
time window | 10 |
survival rate | 10 |
control groups | 9 |
several studies | 9 |
alveolar epithelial | 9 |
dark cycle | 9 |
ace receptor | 9 |
analysis revealed | 9 |
human lung | 9 |
serum albumin | 9 |
blood samples | 9 |
neuroprotective effects | 9 |
cleavage site | 9 |
control mice | 9 |
well plate | 9 |
luminex assay | 9 |
channel protein | 9 |
detected using | 9 |
human angiogenin | 9 |
host cells | 9 |
quality control | 9 |
human colon | 9 |
ml penicillin | 9 |
substantia nigra | 9 |
inflammatory effect | 9 |
cancer treatment | 9 |
flow cytometric | 9 |
protein tyrosine | 9 |
induced mechanical | 9 |
acute ischemic | 9 |
gap junction | 9 |
studies showed | 9 |
response curve | 9 |
secreted frizzled | 9 |
ang variants | 9 |
pro plus | 9 |
colon tissues | 9 |
increased mitochondrial | 9 |
markedly increased | 9 |
novel therapeutic | 9 |
parp cleavage | 9 |
fluorescence microscope | 9 |
cell carcinoma | 9 |
injury via | 9 |
human umbilical | 9 |
nuclear factor | 9 |
tail artery | 9 |
cardiac fibroblast | 9 |
pulmonary arterial | 9 |
proinflammatory response | 9 |
cell entry | 9 |
humidified atmosphere | 9 |
laser scanning | 9 |
sybr green | 9 |
endothelial dysfunction | 9 |
cardiac hypertrophy | 9 |
pulmonary hypertension | 9 |
performed according | 9 |
alone group | 9 |
vascular remodeling | 9 |
mechanisms underlying | 9 |
receptor binding | 9 |
insulin sensitivity | 9 |
melatonin receptor | 9 |
experimental design | 9 |
monoclonal antibody | 9 |
myocardial inflammation | 9 |
cardioprotective effects | 9 |
cell injury | 9 |
dodecyl sulfate | 9 |
induced activation | 9 |
ovarian cancer | 9 |
mouse hearts | 9 |
vivo studies | 9 |
washed three | 9 |
patent medicine | 9 |
lopinavir ritonavir | 9 |
using imagej | 9 |
treatment groups | 9 |
mediated inhibition | 9 |
treatment also | 9 |
myristic acid | 9 |
high affinity | 9 |
like behavior | 9 |
induced changes | 9 |
qt interval | 9 |
cho cells | 9 |
lung homogenates | 9 |
calcium signaling | 9 |
administered sunitinib | 9 |
induced cardiac | 9 |
icariside ii | 9 |
therapeutic agents | 9 |
solution containing | 9 |
neurological disorders | 9 |
ag group | 9 |
blotting analysis | 9 |
bile duct | 9 |
incorporation assay | 9 |
killer cells | 9 |
fusion inhibitors | 9 |
zn cotreatment | 9 |
intracellular calcium | 9 |
promoter activity | 9 |
induced acute | 9 |
innate immunity | 9 |
cytoplasmic vacuolation | 9 |
left ventricular | 9 |
inducing ligand | 9 |
hepatic stellate | 9 |
snail signaling | 9 |
colon tissue | 9 |
large number | 9 |
plasma level | 9 |
reporter plasmid | 9 |
dna repair | 9 |
tyrosine phosphatase | 9 |
protein concentration | 9 |
brdu incorporation | 9 |
fibril formation | 9 |
hpa axis | 9 |
brain infarct | 9 |
vivo study | 9 |
beneficial effects | 9 |
i interferon | 9 |
inflammatory mediators | 9 |
hypoglycemic effect | 9 |
nmt activity | 9 |
binding protein | 9 |
based immunotherapy | 9 |
transfection efficiency | 9 |
may help | 9 |
lung tissue | 9 |
completely blocked | 9 |
endothelial function | 9 |
animal center | 9 |
nsclc cells | 9 |
behavioral tests | 9 |
overlapping molecules | 9 |
penicillin streptomycin | 9 |
induced mitochondrial | 9 |
phase i | 9 |
life technologies | 9 |
autophagy via | 9 |
akt mapk | 8 |
many studies | 8 |
treatment may | 8 |
rat cardiac | 8 |
aneurysm formation | 8 |
tissue sections | 8 |
dimethyl sulfoxide | 8 |
induced hypertension | 8 |
used clinically | 8 |
also inhibited | 8 |
therapeutic drug | 8 |
pharmacological effects | 8 |
day continuously | 8 |
various types | 8 |
similar effects | 8 |
lactate dehydrogenase | 8 |
dose group | 8 |
cd injury | 8 |
potent anticancer | 8 |
dss group | 8 |
pd drug | 8 |
onset frequency | 8 |
protein binds | 8 |
randomized clinical | 8 |
collagen production | 8 |
spectrum antiviral | 8 |
mice exhibited | 8 |
cardiac ischemia | 8 |
neuron loss | 8 |
three separate | 8 |
extracted using | 8 |
may provide | 8 |
goat anti | 8 |
anticancer effects | 8 |
immunogenic cell | 8 |
acute lung | 8 |
randomly selected | 8 |
internal solution | 8 |
sitosterol ameliorates | 8 |
potential target | 8 |
peripheral blood | 8 |
protein aggregation | 8 |
inflammatory injury | 8 |
i overexpression | 8 |
treat covid | 8 |
liver injury | 8 |
cko mouse | 8 |
pathway analysis | 8 |
natural products | 8 |
viral membrane | 8 |
canonical wnt | 8 |
reverse transcriptase | 8 |
spike glycoprotein | 8 |
optimized treatment | 8 |
increasing concentrations | 8 |
zsxbgz decoction | 8 |
transmission electron | 8 |
combination therapy | 8 |
cannabinoid cb | 8 |
foam cell | 8 |
neuronal death | 8 |
significantly enhanced | 8 |
significantly reversed | 8 |
clinical practice | 8 |
upper panel | 8 |
cell volume | 8 |
tumor antigens | 8 |
unbalanced state | 8 |
significant decrease | 8 |
drug discovery | 8 |
normal cells | 8 |
serine threonine | 8 |
balance state | 8 |
fibroblast proliferation | 8 |
nuclear stat | 8 |
cerebral artery | 8 |
potential mechanism | 8 |
flow cytometer | 8 |
autophagic flux | 8 |
cell numbers | 8 |
representative images | 8 |
weeks old | 8 |
propidium iodide | 8 |
positive charge | 8 |
previous reports | 8 |
drug resistance | 8 |
transfection reagent | 8 |
cell infiltration | 8 |
expressed genes | 8 |
via inhibition | 8 |
murine hearts | 8 |
coronavirus spike | 8 |
pathway enrichment | 8 |
epithelial cell | 8 |
receptor agonists | 8 |
significantly different | 8 |
regulatory enzymes | 8 |
current amplitude | 8 |
alexa fluor | 8 |
antitumor effect | 8 |
signaling cascades | 8 |
pressure fluctuation | 8 |
cd cd | 8 |
akt signaling | 8 |
faah inhibitor | 8 |
internal control | 8 |
sirius red | 8 |
neurological diseases | 8 |
mice compared | 8 |
ifn production | 8 |
scanning microscope | 8 |
differences among | 8 |
rat basilar | 8 |
also demonstrated | 8 |
structural basis | 8 |
mammalian cells | 8 |
induces paraptosis | 8 |
drug therapy | 8 |
rheumatoid arthritis | 8 |
formation assay | 8 |
early stage | 8 |
smad pathway | 8 |
luciferase assay | 8 |
i ifn | 8 |
inflammatory cell | 8 |
increased cleaved | 8 |
phosphorylation levels | 8 |
controlled trial | 8 |
vegf pi | 8 |
animal care | 8 |
primary sensory | 8 |
standard deviation | 8 |
rna viruses | 8 |
various tissues | 8 |
middle cerebral | 8 |
myristoylated proteins | 8 |
differentially expressed | 8 |
vital role | 8 |
akt pathway | 8 |
induced autophagy | 8 |
positive neurons | 8 |
growth factors | 8 |
respiration potency | 8 |
kinase inhibitor | 8 |
maf protein | 8 |
may cause | 8 |
morphological changes | 8 |
without gas | 8 |
cells stably | 8 |
pbs containing | 8 |
increased ect | 8 |
polyacrylamide gel | 8 |
ischemic brains | 8 |
biological activities | 8 |
highly expressed | 8 |
cmap dataset | 8 |
microglial cells | 8 |
proinflammatory cytokine | 8 |
autophagy activity | 8 |
incubated overnight | 8 |
via activation | 8 |
death receptor | 8 |
interstitial fibrosis | 8 |
using graphpad | 8 |
confocal laser | 8 |
apoptosis rate | 8 |
tissue samples | 8 |
nociceptive behavior | 8 |
protein assay | 8 |
active caspase | 8 |
cells infected | 8 |
group compared | 8 |
cohort study | 8 |
adverse events | 8 |
cardiac fibrosis | 8 |
dependent pathway | 8 |
human coronavirus | 8 |
neurotrophic factor | 8 |
antibiotic intervention | 8 |
high concentration | 8 |
enos mrna | 8 |
hsc activation | 8 |
subsequent experiments | 8 |
antihypertensive agent | 8 |
metrnl deficiency | 8 |
map kinase | 7 |
horseradish peroxidase | 7 |
sirna transfection | 7 |
tissue explants | 7 |
tab group | 7 |
high concentrations | 7 |
immunohistochemical staining | 7 |
artery myocytes | 7 |
ami mice | 7 |
study indicated | 7 |
flow rate | 7 |
induce apoptosis | 7 |
pcr system | 7 |
vivo imaging | 7 |
ganglion neurons | 7 |
internal standard | 7 |
considered significant | 7 |
catalpol increased | 7 |
normal saline | 7 |
illness course | 7 |
study found | 7 |
potential targets | 7 |
immune microenvironment | 7 |
cardiac damage | 7 |
statistical significance | 7 |
plasma samples | 7 |
days prior | 7 |
hydrogen bond | 7 |
targeted gene | 7 |
renal damage | 7 |
also detected | 7 |
vasopressin receptor | 7 |
low concentrations | 7 |
microarray analysis | 7 |
pk pd | 7 |
rafts caveolae | 7 |
checkpoint inhibitors | 7 |
ameliorates iav | 7 |
myd homodimer | 7 |
light dark | 7 |
ali bx | 7 |
public health | 7 |
inflammatory cytokine | 7 |
mice per | 7 |
ath group | 7 |
protein interaction | 7 |
treated bv | 7 |
membrane rupture | 7 |
brain tissues | 7 |
channel activity | 7 |
induced expression | 7 |
lipid accumulation | 7 |
decreased expression | 7 |
differential expression | 7 |
ros levels | 7 |
cell surface | 7 |
motor impairments | 7 |
left ventricle | 7 |
results show | 7 |
new insights | 7 |
tamoxifen induction | 7 |
lower panel | 7 |
protein concentrations | 7 |
medical university | 7 |
lung epithelial | 7 |
hepatoma cells | 7 |
cruz biotechnology | 7 |
aiii suppressed | 7 |
chemotherapeutic drugs | 7 |
cytokine storm | 7 |
related genes | 7 |
serum levels | 7 |
human non | 7 |
smad expression | 7 |
brain ischemia | 7 |
erk signaling | 7 |
may play | 7 |
level auc | 7 |
cardiomyocyte pyroptosis | 7 |
technology co | 7 |
antimyeloma activity | 7 |
blood glucose | 7 |
ventricular remodeling | 7 |
ramelteon significantly | 7 |
synuclein oligomers | 7 |
two types | 7 |
pharmacological blockade | 7 |
hantavirus infection | 7 |
induced endothelial | 7 |
potential application | 7 |
umbilical vein | 7 |
indicated proteins | 7 |
previous research | 7 |
blood vessels | 7 |
artery occlusion | 7 |
total proteins | 7 |
sham group | 7 |
numerous studies | 7 |
sunitinib may | 7 |
intraperitoneally injected | 7 |
rat drg | 7 |
immunoblot analysis | 7 |
rna polymerase | 7 |
high expression | 7 |
stat phosphorylation | 7 |
antiviral response | 7 |
visualized using | 7 |
mortality rate | 7 |
precursor protein | 7 |
radiation therapy | 7 |
bx zhou | 7 |
data indicated | 7 |
mediated activation | 7 |
bl mice | 7 |
cell membranes | 7 |
related apoptosis | 7 |
based pk | 7 |
red staining | 7 |
novel mechanism | 7 |
vitro studies | 7 |
cardiovascular system | 7 |
drug screening | 7 |
immunity cycle | 7 |
statistical comparisons | 7 |
dose chloroquine | 7 |
combination therapies | 7 |
related diseases | 7 |
densitometric analysis | 7 |
regulatory role | 7 |
like receptors | 7 |
study demonstrates | 7 |
peripheral immune | 7 |
previous report | 7 |
mm kcl | 7 |
united states | 7 |
weak balance | 7 |
rna genome | 7 |
endocannabinoid signaling | 7 |
activated receptor | 7 |
induced flinching | 7 |
bone marrow | 7 |
special issue | 7 |
vitro experiments | 7 |
quantitative real | 7 |
arterial hypertension | 7 |
mts assay | 7 |
cell formation | 7 |
overall survival | 7 |
neurodegenerative disorders | 7 |
clinical applications | 7 |
systemic inflammation | 7 |
fat diet | 7 |
microplate reader | 7 |
overexpression plasmid | 7 |
increased levels | 7 |
pvdf membranes | 7 |
well tolerated | 7 |
human liver | 7 |
downstream signaling | 7 |
imaging system | 7 |
seq analysis | 7 |
ubiquitinated tmem | 7 |
synergistic effect | 7 |
human pancreatic | 7 |
protein bands | 7 |
markedly inhibited | 7 |
factor receptors | 7 |
collagen i | 7 |
branch length | 7 |
agonist pre | 7 |
potential role | 7 |
angiotensin system | 7 |
cardiac cells | 7 |
nucleic acid | 7 |
renal cell | 7 |
bdl rats | 7 |
decreased phosphorylation | 7 |
coupled receptor | 7 |
examined whether | 7 |
risk factor | 7 |
inducible nitric | 7 |
motor functions | 7 |
via sgk | 7 |
molecular network | 7 |
cdna synthesis | 7 |
type iii | 7 |
cell therapy | 7 |
stat tyr | 7 |
polyvinylidene difluoride | 7 |
dependent mechanism | 7 |
cancer gene | 7 |
myd binding | 7 |
antiviral drugs | 7 |
eosin staining | 7 |
basal respiration | 7 |
significant effect | 7 |
anticancer agent | 7 |
cells reached | 7 |
maximal respiration | 7 |
deficient cells | 7 |
apoptosis induced | 7 |
provide new | 7 |
treatment increased | 7 |
hek cells | 7 |
induced toxicity | 7 |
ml streptomycin | 7 |
chronic ischemic | 7 |
mm ca | 7 |
via pi | 7 |
unclear whether | 6 |
depression anxiety | 6 |
dss administration | 6 |
via nf | 6 |
cytometry analysis | 6 |
brain sections | 6 |
immunosorbent assay | 6 |
protein extraction | 6 |
renal disease | 6 |
induced liver | 6 |
normal mice | 6 |
arteries isolated | 6 |
deficit scores | 6 |
neuronal injury | 6 |
fluorescence intensity | 6 |
induce cell | 6 |
plasma metabolites | 6 |
idiopathic pulmonary | 6 |
invasion assay | 6 |
melanoma cells | 6 |
humidified incubator | 6 |
tissues ht | 6 |
mrna level | 6 |
trail protein | 6 |
protein lipidation | 6 |
also increased | 6 |
molecular devices | 6 |
channel blocker | 6 |
heavy metal | 6 |
negative breast | 6 |
induced neuroinflammation | 6 |
inward rectifier | 6 |
chronic administration | 6 |
cell number | 6 |
hantaan virus | 6 |
kg macitentan | 6 |
mi mice | 6 |
homo sapiens | 6 |
dopaminergic neuronal | 6 |
pharmacodynamic parameters | 6 |
using western | 6 |
receptor recognition | 6 |
three drugs | 6 |
threonine kinase | 6 |
neonatal mouse | 6 |
ca channel | 6 |
adrenal axis | 6 |
pi staining | 6 |
pa alone | 6 |
transcription pcr | 6 |
trna fragments | 6 |
biotech co | 6 |
formic acid | 6 |
pharmacologica sinica | 6 |
sgk sirna | 6 |
cardiac myocytes | 6 |
action potentials | 6 |
neuroprotective agent | 6 |
affect cell | 6 |
concentration range | 6 |
downregulated genes | 6 |
evaluated using | 6 |
trail expression | 6 |
clinical features | 6 |
significant reduction | 6 |
syn fibrillation | 6 |
histological analysis | 6 |
rabbit igg | 6 |
bax ratio | 6 |
kidney disease | 6 |
proinflammatory responses | 6 |
inducible dicer | 6 |
chronic schizophrenia | 6 |
sars coronavirus | 6 |
verify whether | 6 |
medicinal plants | 6 |
synthetic cannabinoids | 6 |
functional effects | 6 |
animal studies | 6 |
culture supernatants | 6 |
mouse igg | 6 |
including tnf | 6 |
plasma levels | 6 |
checkpoint blockade | 6 |
fibroblast growth | 6 |
inhibitors may | 6 |
highly conserved | 6 |
intraperitoneal injection | 6 |
small rnas | 6 |
different mechanisms | 6 |
myd inhibitor | 6 |
cells ml | 6 |
induced inhibition | 6 |
high selectivity | 6 |
similarity search | 6 |
type mice | 6 |
target cells | 6 |
analysis data | 6 |
hdc anticancer | 6 |
caspase activation | 6 |
platelet aggregation | 6 |
neonatal rat | 6 |
indicated concentration | 6 |
quantification analysis | 6 |
specific rl | 6 |
ion channel | 6 |
binding proteins | 6 |
mitochondrial pathway | 6 |
time course | 6 |
blotting assays | 6 |
ko ects | 6 |
cell patch | 6 |
liver samples | 6 |
biological technology | 6 |
sd rats | 6 |
rna extraction | 6 |
downstream genes | 6 |
anemarrhena asphodeloides | 6 |
analysis using | 6 |
programmed cell | 6 |
infected group | 6 |
proinflammatory genes | 6 |
crystal structure | 6 |
membrane binding | 6 |
proteasome pathway | 6 |
glucose levels | 6 |
subcutaneous injection | 6 |
stellate cells | 6 |
also shown | 6 |
complementary dna | 6 |
gene transfection | 6 |
least partially | 6 |
cellular signaling | 6 |
sa group | 6 |
clinical study | 6 |
mediated amplification | 6 |
cd uptake | 6 |
dox group | 6 |
hospitalized patients | 6 |
protein complex | 6 |
pathological development | 6 |
acta pharmacologica | 6 |
akt mtor | 6 |
stably transfected | 6 |
medical sciences | 6 |
data presented | 6 |
potential mechanisms | 6 |
inflammatory reactions | 6 |
i knockdown | 6 |
significantly inhibit | 6 |
myeloid leukemia | 6 |
thermo scientific | 6 |
pyroptotic cell | 6 |
cell loss | 6 |
diabetic cardiomyopathy | 6 |
experimental animal | 6 |
treated metrnl | 6 |
cellular morphology | 6 |
induced increase | 6 |
myocardial infarct | 6 |
cell recruitment | 6 |
coupled receptors | 6 |
synthesis kit | 6 |
inducible kinase | 6 |
systemic sclerosis | 6 |
lm treatment | 6 |
drug target | 6 |
results demonstrate | 6 |
different types | 6 |
txnip expression | 6 |
bdl group | 6 |
bioactive component | 6 |
ax foci | 6 |
therapeutic approach | 6 |
dicer conditional | 6 |
induced inflammatory | 6 |
myocardial fibrosis | 6 |
two drugs | 6 |
days later | 6 |
trypan blue | 6 |
new coronavirus | 6 |
panss score | 6 |
normal level | 6 |
endogenous metabolites | 6 |
different time | 6 |
aa groups | 6 |
green fluorescence | 6 |
dorsal root | 6 |
oxidative phosphorylation | 6 |
mediated cell | 6 |
ifn signaling | 6 |
approved drug | 6 |
effective therapeutic | 6 |
randomized controlled | 6 |
vascular wall | 6 |
serum samples | 6 |
linked immunosorbent | 6 |
expression signatures | 6 |
graphpad software | 6 |
cell model | 6 |
mtt assay | 6 |
compensatory unbalanced | 6 |
induced pain | 6 |
vein endothelial | 6 |
patients infected | 6 |
exhibited significant | 6 |
reached mm | 6 |
national institutes | 6 |
upregulated genes | 6 |
migration assay | 6 |
dependent rna | 6 |
heme oxygenase | 6 |
healthy controls | 6 |
usp expression | 6 |
anticancer agents | 6 |
colon carcinoma | 6 |
tissue damage | 6 |
network model | 6 |
pcr total | 6 |
mitochondrial dna | 6 |
collagen synthesis | 6 |
evidence suggests | 6 |
newly synthesized | 6 |
inhibitor cocktail | 6 |
small interfering | 6 |
stock solution | 6 |
inflammatory pain | 6 |
cell metabolism | 6 |
tumor vaccines | 6 |
social function | 6 |
overexpressing sgk | 6 |
regulated kinase | 6 |
quantitative efficacy | 6 |
extracellular signal | 6 |
diabetic mice | 6 |
enrichment analyses | 6 |
adhesion molecules | 6 |
cell biology | 6 |
synuclein imaging | 6 |
via inhibiting | 6 |
stained cells | 6 |
past decade | 6 |
biological processes | 6 |
zn treatment | 6 |
elevated levels | 6 |
activator inhibitor | 6 |
activation via | 6 |
mt overexpression | 6 |
antitumor effects | 6 |
cell killing | 6 |
infected vero | 6 |
sgk mediates | 6 |
brain tissue | 6 |
hydrophobic interactions | 6 |
also known | 6 |
physiological processes | 6 |
autophagy flux | 6 |
cardiomyocyte apoptosis | 6 |
foot faults | 6 |
dendritic cell | 6 |
inverted microscope | 6 |
twice daily | 6 |
receptor activity | 6 |
nrf knockdown | 6 |
cancer progression | 6 |
rna transcription | 6 |
buffer containing | 6 |
tumor suppressor | 6 |
distress syndrome | 6 |
acetic acid | 6 |
male sprague | 6 |
loaded nanoparticles | 6 |
basement membrane | 6 |
colon length | 6 |
nintedanib treatment | 6 |
free access | 6 |
equal amounts | 6 |
following treatment | 6 |
cytometric analysis | 6 |
enhanced chemiluminescence | 6 |
respiratory distress | 6 |
interacting protein | 6 |
protein kinases | 6 |
molecule inhibitors | 6 |
freshly isolated | 6 |
via suppressing | 6 |
increased risk | 6 |
induced oxidative | 6 |
cardiac tissue | 6 |
wide association | 6 |
amyloid precursor | 6 |
containing fbs | 6 |
ht yu | 6 |
targeted therapy | 6 |
cultured cells | 6 |
outer membrane | 6 |
hfd group | 6 |
atherosclerotic plaques | 6 |
icr mice | 6 |
specific sirnas | 6 |
infected mice | 6 |
colonic tissue | 6 |
activity via | 6 |
specific antibodies | 6 |
master mix | 5 |
polyvinylidene fluoride | 5 |
induce dna | 5 |
future studies | 5 |
like symptoms | 5 |
myocardial inflammatory | 5 |
angiotensinconverting enzyme | 5 |
inhibitors mm | 5 |
cell autophagy | 5 |
tumor immunotherapy | 5 |
ect function | 5 |
aiii also | 5 |
term outcomes | 5 |
containing protein | 5 |
mm cells | 5 |
cellular uptake | 5 |
htnv replication | 5 |
cells without | 5 |
deubiquitinase usp | 5 |
drug library | 5 |
lps treatment | 5 |
emission tomography | 5 |
propofol effects | 5 |
female asian | 5 |
brain barrier | 5 |
terminal domain | 5 |
neurodegenerative disease | 5 |
cardioprotective effect | 5 |
pathological phenotypes | 5 |
blotting results | 5 |
lewy neurites | 5 |
human breast | 5 |
th expression | 5 |
band intensities | 5 |
production via | 5 |
representative photographs | 5 |
representative experiment | 5 |
inhibits cell | 5 |
studies demonstrated | 5 |
i herg | 5 |
real time | 5 |
potential anticancer | 5 |
kinase domain | 5 |
natural history | 5 |
ubiquitin ligase | 5 |
sequence similarity | 5 |
clinical application | 5 |
induced nociceptive | 5 |
anion channel | 5 |
hypoxic conditions | 5 |
nanjing jiancheng | 5 |
widely distributed | 5 |
rna isolation | 5 |
potential drug | 5 |
mesenchymal stromal | 5 |
severe covid | 5 |
keloid tissue | 5 |
experimental protocols | 5 |
loading control | 5 |
cardiovascular injury | 5 |
short half | 5 |
clamp experiments | 5 |
significant changes | 5 |
proteins involved | 5 |
extensive attention | 5 |
inflammatory activity | 5 |
tunel staining | 5 |
following cd | 5 |
following tamoxifen | 5 |
pressure fluctuations | 5 |
university animal | 5 |
protease inhibitors | 5 |
stroke patients | 5 |
mobile phase | 5 |
sulfate sodium | 5 |
trail signaling | 5 |
catenin pathway | 5 |
dapi staining | 5 |
wide range | 5 |
glucose metabolism | 5 |
immunosuppressive tumor | 5 |
mediated protection | 5 |
closely associated | 5 |
physiological functions | 5 |
indicated group | 5 |
myristoylated protein | 5 |
calcium channel | 5 |
pivotal role | 5 |
whether lm | 5 |
nmt expression | 5 |
experimental procedures | 5 |
emission wavelength | 5 |
life cycle | 5 |
stress conditions | 5 |
almost completely | 5 |
liver tissue | 5 |
keloid fibroblast | 5 |
protein production | 5 |
wound healing | 5 |
evoked currents | 5 |
regulate autophagy | 5 |
mediated gene | 5 |
monocyte chemoattractant | 5 |
including cancer | 5 |
membrane currents | 5 |
cov infection | 5 |
plasmid transfection | 5 |
drug candidate | 5 |
motor activity | 5 |
showed similar | 5 |
reporter assay | 5 |
adverse reactions | 5 |
foster city | 5 |
seeded onto | 5 |
model parameters | 5 |
myocardial tissues | 5 |
ischemia injury | 5 |
compound imb | 5 |
cannabinoid receptors | 5 |
hr domains | 5 |
regional dyssynchrony | 5 |
meets immunotherapy | 5 |
significantly changed | 5 |
endocannabinoid receptors | 5 |
potent antimyeloma | 5 |
including anti | 5 |
cardiovascular complications | 5 |
ritanserin concentration | 5 |
via blocking | 5 |
acute application | 5 |
study identified | 5 |
induces il | 5 |
antihypertensive agents | 5 |
receptor activation | 5 |
rabbit anti | 5 |
aiii inhibits | 5 |
several key | 5 |
medical college | 5 |
intracellular ros | 5 |
culture supernatant | 5 |
novel biphenyl | 5 |
human nmt | 5 |
ameliorates hepatic | 5 |
muscle actin | 5 |
viral entry | 5 |
informed consent | 5 |
factor receptor | 5 |
oral gavage | 5 |
related cardiovascular | 5 |
sgk phosphorylation | 5 |
molecular weight | 5 |
viral infections | 5 |
nrf protein | 5 |
use committee | 5 |
selective autophagy | 5 |
muscle mitochondrial | 5 |
like phenotypes | 5 |
endogenous cannabinoid | 5 |
control rats | 5 |
potent inhibitor | 5 |
ip ib | 5 |
state inactivation | 5 |
selective sigma | 5 |
chronic kidney | 5 |
life span | 5 |
oroxindin protects | 5 |
remain unclear | 5 |
clinical diagnosis | 5 |
apoptotic cell | 5 |
caspase expression | 5 |
inflammatory process | 5 |
versus iav | 5 |
clinical use | 5 |
dss drinking | 5 |
motor ability | 5 |
adult rat | 5 |
intercellular communication | 5 |
multiple comparison | 5 |
accident victims | 5 |
rodent models | 5 |
independent translation | 5 |
arrestin mediates | 5 |
regulatory effects | 5 |
like effects | 5 |
promising strategy | 5 |
rotarod test | 5 |
myocardial apoptosis | 5 |
stress granules | 5 |
calculated using | 5 |
clinical symptoms | 5 |
cell invasion | 5 |
sfas ligand | 5 |
structural proteins | 5 |
rats via | 5 |
like cells | 5 |
hydrolase inhibitor | 5 |
autoimmune diseases | 5 |
conjugated goat | 5 |
activity index | 5 |
studies show | 5 |
compound lm | 5 |
positron emission | 5 |
coronavirus infection | 5 |
protein modification | 5 |
dependent reduction | 5 |
three antipsychotics | 5 |
tolerance test | 5 |
mtdna copy | 5 |
murine ect | 5 |
dual faah | 5 |
oroxindin treatment | 5 |
expression profile | 5 |
dmem supplemented | 5 |
receptor ace | 5 |
via activating | 5 |
erk activation | 5 |
copy number | 5 |
causal relationship | 5 |
type ca | 5 |
pd pathogenesis | 5 |
mouse ventricular | 5 |
cell fusion | 5 |
angiogenin variants | 5 |
multiple cellular | 5 |
gold standard | 5 |
including il | 5 |
tamoxifen vs | 5 |
time quantitative | 5 |
triplicate samples | 5 |
vaccine delivery | 5 |
chronic hepatitis | 5 |
synaptic plasticity | 5 |
patients receiving | 5 |
fluorescent protein | 5 |
vascular function | 5 |
scr levels | 5 |
immunofluorescent staining | 5 |
calcium homeostasis | 5 |
tail length | 5 |
study groups | 5 |
many types | 5 |
explore whether | 5 |
cells exposed | 5 |
one representative | 5 |
chain fatty | 5 |
ath subgroups | 5 |
cardiac complications | 5 |
saint louis | 5 |
cell nucleus | 5 |
quantitative pcr | 5 |
strand cdna | 5 |
positively correlated | 5 |
like protease | 5 |
enzyme inhibitors | 5 |
amplified using | 5 |
east respiratory | 5 |
targeting spectrum | 5 |
muscle fiber | 5 |
information data | 5 |
low ph | 5 |
per week | 5 |
normal function | 5 |
death domain | 5 |
kit according | 5 |
also involved | 5 |
motor function | 5 |
induced enmt | 5 |
neutralizing antibody | 5 |
respiratory syncytial | 5 |
death receptors | 5 |
kinase inhibitors | 5 |
renal hypertrophy | 5 |
myeloma xenografts | 5 |
future perspectives | 5 |
nle inhibited | 5 |
indicated time | 5 |
cardiac diseases | 5 |
advanced stages | 5 |
acetate levels | 5 |
novel human | 5 |
nicotinic acetylcholine | 5 |
syncytial virus | 5 |
data indicate | 5 |
aiii reduced | 5 |
cell configuration | 5 |
myeloma cell | 5 |
pathological mechanism | 5 |
evolutionarily conserved | 5 |
mitochondrial network | 5 |
da neuronal | 5 |
rats compared | 5 |
serious adverse | 5 |
pulmonary artery | 5 |
important target | 5 |
final model | 5 |
ampk activation | 5 |
liver cancer | 5 |
induced vascular | 5 |
widely expressed | 5 |
mouse primary | 5 |
findings provide | 5 |
isre activity | 5 |
elisa kit | 5 |
culture dishes | 5 |
significantly enriched | 5 |
bar graphs | 5 |
three genes | 5 |
kegg pathways | 5 |
induced proliferation | 5 |
cytoplasmic vacuoles | 5 |
serine protease | 5 |
synthesis inhibitors | 5 |
progressive loss | 5 |
transcriptional regulation | 5 |
various diseases | 5 |
transwell assay | 5 |
patch clamp | 5 |
drug effect | 5 |
identified mebendazole | 5 |
seq data | 5 |
different groups | 5 |
prefusion conformation | 5 |
middle east | 5 |
hypertensive rats | 5 |
leukemia cell | 5 |
agilent technologies | 5 |
receptor type | 5 |
repeated three | 5 |
pole test | 5 |
expressing cells | 5 |
ramelteon may | 5 |
chemoattractant protein | 5 |
bd biosciences | 5 |
lianhua qingwen | 5 |
renoprotective effects | 5 |
injury induced | 5 |
huvec cells | 5 |
activation may | 5 |
protein family | 5 |
blood flow | 5 |
three different | 5 |
creatine kinase | 5 |
detection kit | 5 |
microglial activation | 5 |
mg twice | 5 |
hfd mice | 5 |
positively charged | 5 |
body weights | 5 |
immune cell | 5 |
asian chest | 5 |
maf ubiquitination | 5 |
th day | 5 |
like behaviors | 5 |
dextran sulfate | 5 |
drug design | 5 |
cmr combined | 5 |
dicer depletion | 5 |
toluidine blue | 5 |
calf serum | 5 |
iii ifn | 5 |
biphenyl compound | 5 |
epithelial metrnl | 5 |
different regions | 5 |
shrna expression | 5 |
herbal medicines | 5 |
using lipofectamine | 5 |
progenitor cells | 5 |
protein translation | 5 |
elisa kits | 5 |
direct interaction | 5 |
early stages | 5 |
activated cl | 5 |
also able | 5 |
primer sequences | 5 |
mouse embryonic | 5 |
cytosolic ca | 5 |
clinical evidence | 5 |
targeting strategies | 5 |
receptor subtypes | 5 |
antiparkinsonian effects | 5 |
results described | 5 |
analysis western | 5 |
relatively low | 5 |
human macrophages | 5 |
atr activation | 5 |
angiogenin protein | 5 |
targeting sars | 5 |
fibrosis via | 5 |
human subjects | 5 |
apoptosis assay | 5 |
vivo model | 5 |
duct proliferation | 5 |
protective mechanism | 5 |
killer cell | 5 |
genes related | 5 |
chd network | 5 |
atg plays | 5 |
first evidence | 5 |
reverse transcribed | 5 |
trail dna | 5 |
pd ad | 5 |
bearing mice | 5 |
keloid pathogenesis | 5 |
qtc interval | 5 |
randomly separated | 5 |
results provide | 5 |
indicated times | 5 |
endogenous cannabinoids | 5 |
potential new | 5 |
ring structure | 5 |
fetal calf | 5 |
dependent effect | 5 |
serum rl | 5 |
isre luciferase | 5 |
culture collection | 5 |
tumor volumes | 5 |
cell nuclei | 5 |
molecular basis | 5 |
difluoride membranes | 5 |
previously published | 5 |
lps group | 5 |
nanomedicine meets | 5 |
klx significantly | 5 |
may yield | 5 |
also plays | 5 |
antigen presentation | 5 |
ml min | 5 |
dysfunction induced | 5 |
previous experimental | 5 |
novel potential | 5 |
ang gene | 5 |
also confirmed | 5 |
experimental conditions | 5 |
urgently needed | 5 |
disease activity | 5 |
accumulating evidence | 5 |
pathway date | 5 |
pathological conditions | 5 |
ii cells | 5 |
macrophage infiltration | 5 |
fusion inhibitor | 5 |
uc model | 5 |
studies identified | 5 |
san diego | 5 |
psp score | 5 |
agarose beads | 5 |
cell function | 5 |
aneurysmatic disease | 5 |
new drug | 5 |
dopamine neurons | 5 |
rat hearts | 5 |
virus infections | 5 |
kg body | 5 |
dataset analysis | 5 |
significantly elevated | 5 |
functional recovery | 5 |
inversely correlated | 4 |
induced cognitive | 4 |
ventricular cardiomyocytes | 4 |
system diseases | 4 |
neutralizing antibodies | 4 |
nrf pathway | 4 |
cell receptor | 4 |
animal experiment | 4 |
cervical cancer | 4 |
protects mice | 4 |
treatment alleviated | 4 |
bioengineering institute | 4 |
angiogenic activity | 4 |
ribonuclease inhibitor | 4 |
cells stimulated | 4 |
bca protein | 4 |
receptor kinases | 4 |
root ganglion | 4 |
ect dysfunction | 4 |
fc fragments | 4 |
inward current | 4 |
cd content | 4 |
gas exchange | 4 |
well known | 4 |
subsequent studies | 4 |
target cell | 4 |
effector caspases | 4 |
endothelin receptors | 4 |
animal ethics | 4 |
cytokine production | 4 |
ifn induction | 4 |
genes associated | 4 |
nervous systems | 4 |
pretreated group | 4 |
sgk protein | 4 |
clinical outcomes | 4 |
specific binding | 4 |
experimental models | 4 |
apoptotic protein | 4 |
world hantavirus | 4 |
wnt pathway | 4 |
cardiac contractility | 4 |
whether ramelteon | 4 |
mouse body | 4 |
angiotensin converting | 4 |
clinical treatment | 4 |
antidepressant effect | 4 |
negatively charged | 4 |
renal dysfunction | 4 |
promoter region | 4 |
rl levels | 4 |
induces autophagy | 4 |
heptad repeat | 4 |
cells express | 4 |
drug efficacy | 4 |
gas significantly | 4 |
rat caudal | 4 |
china pharmaceutical | 4 |
ca concentration | 4 |
cytoprotective effects | 4 |
mebendazole downregulated | 4 |
total number | 4 |
transit compartments | 4 |
various cancers | 4 |
mebendazole inhibits | 4 |
mock group | 4 |
drugs targeting | 4 |
asic subunits | 4 |
therapeutic candidate | 4 |
proteasomal degradation | 4 |
based drug | 4 |
electron microscope | 4 |
tail main | 4 |
suckling mice | 4 |
cells compared | 4 |
ad libitum | 4 |
negative symptoms | 4 |
indicated antibodies | 4 |
tyrosine kinases | 4 |
renohypertensive rat | 4 |
clinical translation | 4 |
viral challenge | 4 |
ang mutations | 4 |
wild type | 4 |
specific inhibitor | 4 |
consecutive weeks | 4 |
virus production | 4 |
university school | 4 |
cells timosaponin | 4 |
killing effect | 4 |
worth mentioning | 4 |
trail plasmid | 4 |
response element | 4 |
selleck chemicals | 4 |
cell models | 4 |
group infected | 4 |
immediate treatment | 4 |
isosibiricin exerts | 4 |
novel myd | 4 |
evoked nf | 4 |
also revealed | 4 |
transmembrane signaling | 4 |
autophagy levels | 4 |
dopaminergic cell | 4 |
molecular tweezer | 4 |
test whether | 4 |
dmem containing | 4 |
increasing attention | 4 |
sample size | 4 |
provide evidence | 4 |
pathway gastrodin | 4 |
peptide derived | 4 |
transient receptor | 4 |
time point | 4 |
recent progress | 4 |
stress markers | 4 |
cells expressing | 4 |
nigrostriatal dopaminergic | 4 |
bca assay | 4 |
progressive changes | 4 |
mitochondrial transcription | 4 |
cell proteases | 4 |
homodimer formation | 4 |
significant attenuation | 4 |
differential metabolites | 4 |
schizophrenia patients | 4 |
activates ppar | 4 |
clamp pulses | 4 |
homologous recombination | 4 |
syn transgenic | 4 |
mitochondrial fragmentation | 4 |
inhibited vegf | 4 |
polymerase chain | 4 |
spinal cord | 4 |
new insight | 4 |
decreased following | 4 |
ruptured abdominal | 4 |
receptor family | 4 |
severe pandemic | 4 |
suppress tumor | 4 |
protein containing | 4 |
another study | 4 |
cytokine expression | 4 |
ramelteon treatment | 4 |
mice bearing | 4 |
standard error | 4 |
lewy body | 4 |
treatment blocked | 4 |
kegg pathway | 4 |
motor neurons | 4 |
camostat mesilate | 4 |
vs ram | 4 |
arterial specimens | 4 |
cell lysate | 4 |
pharmaceutical university | 4 |
antigen expression | 4 |
activated receptors | 4 |
proliferation via | 4 |
inhibitor urb | 4 |
induced epithelial | 4 |
presence size | 4 |
mitochondrial footprint | 4 |
animal research | 4 |
cell experiments | 4 |
supporting information | 4 |
stimulated gene | 4 |
tyrosine phosphorylation | 4 |
rate constant | 4 |
cadmium exposure | 4 |
dependent increase | 4 |
group received | 4 |
ameliorates renal | 4 |
broadspectrum antiviral | 4 |
volume regulation | 4 |
intrarenal renin | 4 |
therapeutic agent | 4 |
including tgf | 4 |
systemic lupus | 4 |
attenuates lipopolysaccharide | 4 |
chloroquine derivatives | 4 |
heart diseases | 4 |
efficacy values | 4 |
profibrotic proteins | 4 |
sen university | 4 |
cardiac myoblasts | 4 |
tumor metastasis | 4 |
lupus erythematosus | 4 |
apoptosis kit | 4 |
alzheimer disease | 4 |
versus ifn | 4 |
trial design | 4 |
valepotriate derivatives | 4 |
also examined | 4 |
various biological | 4 |
increased sgk | 4 |
max value | 4 |
hiv infection | 4 |
tight junction | 4 |
mental health | 4 |
right panel | 4 |
similar therapeutic | 4 |
first experiment | 4 |
experimental report | 4 |
episode schizophrenia | 4 |
evans blue | 4 |
study provides | 4 |
tissue fibrosis | 4 |
antitumor immunity | 4 |
confocal microscopy | 4 |
endogenous ligand | 4 |
nucleoside analog | 4 |
leading cause | 4 |
cultured keloid | 4 |
viral clearance | 4 |
mouse liver | 4 |
ligand binding | 4 |
diabetic patients | 4 |
ritanserin inhibition | 4 |
mice lacking | 4 |
hub nodes | 4 |
like behavioral | 4 |
yuan liu | 4 |
working concentration | 4 |
dopaminergic neuron | 4 |
targeting cancer | 4 |
critical roles | 4 |
nm bay | 4 |
severe symptoms | 4 |
terminal kinase | 4 |
threonine metabolism | 4 |
within min | 4 |
chinese herbal | 4 |
studies also | 4 |
stress response | 4 |
normal artery | 4 |
proinflammatory mediator | 4 |
cultured kfs | 4 |
conferred neuroprotection | 4 |
metabolic diseases | 4 |
also performed | 4 |
inhibitor jzl | 4 |
uranyl acetate | 4 |
iii ifns | 4 |
panel shows | 4 |
lm mitigates | 4 |
pretreatment significantly | 4 |
inhalational anesthetics | 4 |
tlr nf | 4 |
downstream target | 4 |
heat shock | 4 |
antiviral agents | 4 |
mm activity | 4 |
high levels | 4 |
without obvious | 4 |
viral particles | 4 |
kf proliferation | 4 |
viable cells | 4 |
colon sections | 4 |
protein structure | 4 |
unique roles | 4 |
mean inactivation | 4 |
stromal cells | 4 |
vs tamoxifen | 4 |
mature il | 4 |
new member | 4 |
myristoyl motif | 4 |
generated using | 4 |
induced myocardial | 4 |
combined treatment | 4 |
nac region | 4 |
receptor tyrosine | 4 |
main active | 4 |
troponin i | 4 |
based metabolomics | 4 |
lc ii | 4 |
protein degradation | 4 |
inducible gene | 4 |
representative photomicrographs | 4 |
control conditions | 4 |
clinical manifestations | 4 |
including pd | 4 |
cb cb | 4 |
acetylcholine receptors | 4 |
lived proteins | 4 |
inhibited inflammasome | 4 |
obtained using | 4 |
uuo groups | 4 |
virus titers | 4 |
consecutively phosphated | 4 |
pipette solution | 4 |
dependent protein | 4 |
cross talk | 4 |
ms analysis | 4 |
cancer treatments | 4 |
every days | 4 |
trpv activation | 4 |
blocking buffer | 4 |
type culture | 4 |
markedly decreased | 4 |
ath groups | 4 |
nonlinear mixed | 4 |
latest diagnosis | 4 |
human hepatoma | 4 |
glycerolipid metabolism | 4 |
beyotime institute | 4 |
first recurrence | 4 |
nadph oxidase | 4 |
caudal artery | 4 |
sgk activation | 4 |
reports showed | 4 |
channel activation | 4 |
specific cd | 4 |
rat brain | 4 |
free drug | 4 |
vivo models | 4 |
blinded manner | 4 |
genetically engineered | 4 |
mouse brain | 4 |
pressure regulation | 4 |
exerts protective | 4 |
current clinical | 4 |
network analysis | 4 |
stranded rna | 4 |
paw withdrawal | 4 |
also provides | 4 |
following experiments | 4 |
estimated based | 4 |
quantitative measurements | 4 |
second messenger | 4 |
confocal microscope | 4 |
ge healthcare | 4 |
binding region | 4 |
rat liver | 4 |
fractional shortening | 4 |
regulated gene | 4 |
chloride channels | 4 |
generation sequencing | 4 |
cancer antigens | 4 |
liver cells | 4 |
samples collected | 4 |
i sirnas | 4 |
clinical data | 4 |
possible involvement | 4 |
study revealed | 4 |
viral antigen | 4 |
sun yat | 4 |
tubular mitochondria | 4 |
chronic cerebral | 4 |
cycle analysis | 4 |
therapeutic approaches | 4 |
fibrils compared | 4 |
assay cell | 4 |
free dmem | 4 |
analysis cells | 4 |
synergistic antitumor | 4 |
underlying molecular | 4 |
apoptosis induction | 4 |
biological systems | 4 |
help us | 4 |
artery ligation | 4 |
previously observed | 4 |
clinical implications | 4 |
immune activation | 4 |
mapk pathways | 4 |
asic blocker | 4 |
decoction groups | 4 |
clinical severity | 4 |
mitochondria isolation | 4 |
subcellular localization | 4 |
promising drug | 4 |
sgk silencing | 4 |
dutp nick | 4 |
rat aorta | 4 |
inhibiting nlrp | 4 |
ribonuclease activity | 4 |
metabolic pathway | 4 |
kinase pathways | 4 |
eukaryotic cells | 4 |
ta muscles | 4 |
second day | 4 |
null mice | 4 |
synthesized proteins | 4 |
sunitinib administration | 4 |
combining nanomedicines | 4 |
family members | 4 |
virus fusion | 4 |
another min | 4 |
cultured arcfs | 4 |
antipsychotic treatment | 4 |
autophagy deficiency | 4 |
reached confluence | 4 |
attenuates myocardial | 4 |
col i | 4 |
potential vanilloid | 4 |
might help | 4 |
hoc analysis | 4 |
mean branch | 4 |
group comparisons | 4 |
tissue inflammation | 4 |
specific pathogen | 4 |
negatively regulates | 4 |
key regulators | 4 |
quantitative information | 4 |
also indicated | 4 |
viability assay | 4 |
kidney tissues | 4 |
including angiogenesis | 4 |
drug interactions | 4 |
related disorders | 4 |
open repair | 4 |
dependent signaling | 4 |
drg neuron | 4 |
apoptosis detection | 4 |
next examined | 4 |
short hairpin | 4 |
transfection group | 4 |
network modeling | 4 |
metrnl shrna | 4 |
genomic rna | 4 |
without causing | 4 |
induces cell | 4 |
may serve | 4 |
transient transfection | 4 |
rnai plasmid | 4 |
pp ca | 4 |
rna using | 4 |
different treatments | 4 |
pkc signaling | 4 |
promotes cell | 4 |
franklin lakes | 4 |
nk cell | 4 |
optical density | 4 |
indicated treatments | 4 |
shock protein | 4 |
avp induces | 4 |
drug concentration | 4 |
human brain | 4 |
src family | 4 |
trypsin inhibitor | 4 |
type receptor | 4 |
term effects | 4 |
frontal cortex | 4 |
induces mm | 4 |
without nintedanib | 4 |
tht assay | 4 |
dengue virus | 4 |
fluorescence microscopy | 4 |
safe concentration | 4 |
decreased significantly | 4 |
effective time | 4 |
hr region | 4 |
immune reaction | 4 |
reduce cd | 4 |
sgk activity | 4 |
cumulative dose | 4 |
ii diabetes | 4 |
semiquantitative analyses | 4 |
peripheral nervous | 4 |
mainly enriched | 4 |
phase iii | 4 |
physiological conditions | 4 |
ca channels | 4 |
significant dose | 4 |
mouse line | 4 |
aggregation process | 4 |
podocarpus nagi | 4 |
highly pathogenic | 4 |
pretreatment ameliorated | 4 |
therapeutic effect | 4 |
also induced | 4 |
staining showed | 4 |
experimental model | 4 |
applied biosystems | 4 |
many clinical | 4 |
insulin signalling | 4 |
mediated induction | 4 |
mapk activation | 4 |
targeted delivery | 4 |
drd inhibitors | 4 |
levels increased | 4 |
acute myeloid | 4 |
ms ms | 4 |
cells apoptosis | 4 |
oxide pathway | 4 |
cell type | 4 |
cells angiogenin | 4 |
downstream targets | 4 |
improves cardiac | 4 |
cellular functions | 4 |
induced trna | 4 |
screening model | 4 |
hyperalgesia induced | 4 |
jiancheng bioengineering | 4 |
mainly expressed | 4 |
association studies | 4 |
vascular tone | 4 |
inhibitors targeting | 4 |
diagnostic criteria | 4 |
consecutive days | 4 |
degradation via | 4 |
consecutive phosphorylation | 4 |
cardiovascular conditions | 4 |
adaptive immunity | 4 |
drug administration | 4 |
ramelteon protected | 4 |
quantified using | 4 |
tissue culture | 4 |